A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Clinical trial NCT00001381 · COMPLETED

Trial details

NCT number: NCT00001381
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Neoplasms Carcinoma, Transitional Cell

Start date: 1994-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.